RoB 2: a revised tool for assessing risk of bias in randomised trials.
Sterne, JA
; Savović, J; Page, MJ; Elbers, RG; Blencowe, NS; Boutron, I; Cates, CJ; Cheng, H; Corbett, MS; Eldridge, SM; +18 more...Emberson, JR; Hernán, MA; Hopewell, S; Hróbjartsson, A; Junqueira, DR; Jüni, P; Kirkham, JJ; Lasserson, T; Li, T; McAleenan, A; Reeves, BC; Shepperd, S
; Shrier, I; Stewart, LA; Tilling, K; White, IR; Whiting, PF; Higgins, JP and
(2019)
RoB 2: a revised tool for assessing risk of bias in randomised trials.
BMJ (Clinical research ed.), 366.
l4898-.
ISSN 0959-8138
DOI: 10.1136/bmj.l4898
Assessment of risk of bias is regarded as an essential component of a systematic review on the effects of an intervention. The most commonly used tool for randomised trials is the Cochrane risk-of-bias tool. We updated the tool to respond to developments in understanding how bias arises in randomised trials, and to address user feedback on and limitations of the original tool.
Item Type | Article |
---|---|
Elements ID | 137239 |
Date Deposited | 24 Sep 2019 14:36 |
ORCID: https://orcid.org/0000-0001-8496-6053
ORCID: https://orcid.org/0000-0001-6384-8322